Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92012179 | 9201217 | 9 | F | 20130317 | 20160822 | 20130401 | 20160825 | EXP | PHHY2013CA028458 | NOVARTIS | 41.49 | YR | F | Y | 0.00000 | 20160825 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92012179 | 9201217 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, ONCE A MONTH (QMO) | U | 21008 | 30 | MG | /month | ||||||
| 92012179 | 9201217 | 2 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | TEST DOSE, ONCE/SINGLE | 0 | 1X | |||||||||
| 92012179 | 9201217 | 3 | C | GEN-TRAZODONE | 2 | Unknown | U | 0 | |||||||||||
| 92012179 | 9201217 | 4 | C | CHOLESTYRAMINE. | CHOLESTYRAMINE | 1 | Unknown | UNK, QD | U | 0 | QD | ||||||||
| 92012179 | 9201217 | 5 | C | ADVEL | 2 | Unknown | UNK, PRN | U | 0 | ||||||||||
| 92012179 | 9201217 | 6 | C | GRAVOL | DIMENHYDRINATE | 1 | Unknown | UNK, PRN | U | 0 | SUPPOSITORY |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92012179 | 9201217 | 1 | Carcinoid tumour of the small bowel |
| 92012179 | 9201217 | 2 | Carcinoid tumour of the small bowel |
| 92012179 | 9201217 | 3 | Product used for unknown indication |
| 92012179 | 9201217 | 4 | Diarrhoea |
| 92012179 | 9201217 | 5 | Headache |
| 92012179 | 9201217 | 6 | Nausea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92012179 | 9201217 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92012179 | 9201217 | Alopecia | |
| 92012179 | 9201217 | Anxiety | |
| 92012179 | 9201217 | Blood pressure increased | |
| 92012179 | 9201217 | Blood pressure systolic increased | |
| 92012179 | 9201217 | Body temperature decreased | |
| 92012179 | 9201217 | Diarrhoea | |
| 92012179 | 9201217 | Eczema | |
| 92012179 | 9201217 | Hepatic lesion | |
| 92012179 | 9201217 | Injection site haemorrhage | |
| 92012179 | 9201217 | Injection site hypoaesthesia | |
| 92012179 | 9201217 | Nasopharyngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92012179 | 9201217 | 1 | 20100913 | 0 | ||
| 92012179 | 9201217 | 2 | 20100719 | 20100719 | 0 |